UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.96 -0.04 (-0.05%) GOLD FUTURES
2,313.60 +2.60 (+0.11%) DOW
38,152.35 +249.06 (+0.66%) Bitcoin GBP
47,243.24 +1,295.89 (+2.82%)
Brainstorm Cell Therapeutics Inc. (BCLI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:49PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 29.50M |
| Enterprise value | 29.47M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 65.82 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.39 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.29 |
| 52-week change 3 | -86.56% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 3.3400 |
| 52-week low 3 | 0.1300 |
| 50-day moving average 3 | 0.4826 |
| 200-day moving average 3 | 0.6133 |
Share statistics
| Avg vol (3-month) 3 | 985.77k |
| Avg vol (10-day) 3 | 708.96k |
| Shares outstanding 5 | 68.34M |
| Implied shares outstanding 6 | 68.34M |
| Float 8 | 60.8M |
| % held by insiders 1 | 13.27% |
| % held by institutions 1 | 5.97% |
| Shares short (15 Apr 2024) 4 | 1.99M |
| Short ratio (15 Apr 2024) 4 | 1.27 |
| Short % of float (15 Apr 2024) 4 | 3.04% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.91% |
| Shares short (prior month 15 Mar 2024) 4 | 850.26k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 16 Sept 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -211.70% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -21.17M |
| Net income avi to common (ttm) | -17.19M |
| Diluted EPS (ttm) | -0.4000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.3M |
| Total cash per share (mrq) | 0.02 |
| Total debt (mrq) | 1.27M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.24 |
| Book value per share (mrq) | -0.08 |
Cash flow statement
| Operating cash flow (ttm) | -20.46M |
| Levered free cash flow (ttm) | -12.49M |
© 2024 Yahoo. All rights reserved.